Tumor-infiltrating MDSCs could also recruit CCR5+ Tregs to the tumor site through releasing CCR5 ligands CCL3, CCL4, and CCL5 to promote tumor growth in a B16 melanoma model [31]. Here, CCL3 is linked to neoplasm.